GlaxoSmithKline PLC (GSK) and Human Genome Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted a priority review designation to Benlysta® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE).

Original Source of GlaxoSmithKline and Human Genome Sciences announce FDA priority review designation for…

Bristol-Myers Squibb Company (NYSE: BMY) has announced that the U.S. Food and Drug Administration (FDA) has accepted, for filing and review, the Biologics License Application (BLA) for ipilimumab for the treatment of adult patients with advanced melanoma who have been previously treated.

Original Source of Ipilimumab Receives FDA Priority Review…

Eli Lilly and Company (NYSE: LLY) will halt development of semagacestat, a gamma secretase inhibitor being studied as a potential treatment for Alzheimer’s disease,

Original Source of Lilly Halts Development of Semagacestat for Alzheimer’s Disease

The U.S. Food and Drug Administration proposed to withdraw approval of the drug midodrine hydrochloride, used to treat the low blood pressure condition orthostatic hypotension, because required post-approval studies that verify the clinical benefit of the drug have not been done.

Original Source of FDA Proposes Withdrawal of Low Blood…

Many companies in the cell therapy regenerative medicine market including Roche, Genzyme, Athersys, Miltenyi Biotec, Hospira, Lonza and Life Technologies will join ISCT to launch a series of new initiatives that will create greater strategic alignment within the industry and drive late stage clinical development.

Original Source of International Society…

Pharmaceutical and healthcare market research company Manhattan Research releases the tenth version of ePharma Physician®, its study focused on physicians connecting with pharmaceutical and biotech companies through the Internet, tech-enabled reps, and online promotion.

Original Source of Data on Electronic Sampling, Online Promotion, Tech-Enabled Reps, Customer Service, and iPads

H. Lundbeck A/S (Lundbeck) reports second quarter revenue of DKK 3,767 million. An increase of 7% compared to the second quarter results of 2009. Profit from operations was DKK 936 million, an increase of 30% compared to the same period last year.

Original Source of Lundbeck reports strongly increasing profits…

August marks National Psoriasis Awareness Month, an opportunity to raise awareness about psoriasis, a skin disease that affects nearly 7.5 million Americans. For those living with this condition, finding information about what’s happening to them can be a challenge.

Original Source of Abbott Launches New Psoriasisanswers.com Web site

The European Medicines Agency (EMA) and the Food and Drug Administration of the United States of America (US FDA) continue to seek potential candidate companies for a joint GMP inspection pilot programme for manufacturers of medicinal products.

Original Source of EMA and US FDA seek potential candidate companies for joint…

30 September 2010, Frankfurt, Germany. Pharma Marketing 2010 in Frankfurt provides a key platform for Europe’s pharmaceutical industry stakeholders, such as yourself, to discover how best to tackle the key challenges of a price-sensitive and increasingly competitive and rapidly changing market.

Original Source of Pharma Marketing 2010 – Frankfurt